Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

Zimmer Biomet Holdings, Inc. (ZBH) Stock Price: $87.97+0.81 (+0.93%)

At close: Jun 18, 2026, 4:00 PM ET

The closing share price for Zimmer Biomet Holdings, Inc. (ZBH) stock was $87.97 for Thursday, June 18, 2026, up 0.93% on the day.

Longer view (total return, dividends reinvested): past 12 months -1.8% · 3-year avg -14.4%/yr · 5-year avg -9.8%/yr

ZBH Price Chart

End-of-day pricesAdvanced chart →
ZBH$87.97 -3.86%(1Y)as of Jun 18, 2026

ZBH Earnings Preview

Next Earnings Date

Aug 6, 2026

47 days away

EPS Estimate

1.99

Revenue Est.

$2.14B

Last Quarter Results

EPS

$2.09

vs Estimate

$1.86

Beat

Revenue

$2.09B

vs Estimate

$2.07B

Met

ZBH Analyst Ratings

Consensus Rating

Hold

Based on 20 analysts

Strong Buy
2
Buy
6
Hold
17
Sell
1
Strong Sell
0

Average Price Target

$98.70

+12.2% upside

Low

$83.00

Current

$87.97

High

$130.00

ZBH Analyst Estimates

Forward P/E: 9.77

Earnings Per Share (EPS) Estimates

Quarterly

PeriodAvg# Analysts
Q1 2027$2.086
Q2 2027$2.236
Q3 2027$2.126
Q4 2027$2.636

Annual

PeriodAvg# Analysts
FY 2027$9.0116
FY 2028$9.658

Revenue Estimates

Quarterly

PeriodAvg# Analysts
Q1 2027$2.15B7
Q2 2027$2.21B7
Q3 2027$2.12B7
Q4 2027$2.38B7

Annual

PeriodAvg# Analysts
FY 2027$8.85B19
FY 2028$9.19B18

Source: FMP Analyst Consensus Estimates. Forward P/E uses the next-fiscal-year consensus EPS estimate (the same value shown in the Key Metrics strip).

ZBH Competitors' Key Metrics

StockMarket CapTTM Total ReturnCompare
1ZBH$17.02B-1.84%
2HOLX$16.97B+24.08%vs ZBH
3DVA$13.34B+53.16%vs ZBH
4MEDP$13.14B+52.08%vs ZBH
5SOLV$13.06B+3.86%vs ZBH
6LH$20.98B-1.09%vs ZBH

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos